BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 389771)

  • 1. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
    Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
    Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease.
    Mendelsohn G; Wells SA; Baylin SB
    Cancer; 1984 Aug; 54(4):657-62. PubMed ID: 6378353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of immunochemically staining calcitonin and CEA in fine-needle aspiration biopsy materials from medullary carcinoma of the thyroid.
    Takeichi N; Ito H; Okamoto H; Matsuyama T; Tahara E; Dohi K
    Jpn J Surg; 1989 Nov; 19(6):674-8. PubMed ID: 2607690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial markers in thyroid carcinoma: an immunoperoxidase study.
    Wilson NW; Pambakian H; Richardson TC; Stokoe MR; Makin CA; Heyderman E
    Histopathology; 1986 Aug; 10(8):815-29. PubMed ID: 2428725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
    Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
    Surg Forum; 1979; 30():120-1. PubMed ID: 395674
    [No Abstract]   [Full Text] [Related]  

  • 6. Medullary differentiation of anaplastic thyroid carcinoma.
    Nieuwenhuijzen Kruseman AC; Bosman FT; van Bergen Henegouw JC; Cramer-Knijnenburg G; Brutel de la Riviere G
    Am J Clin Pathol; 1982 May; 77(5):541-7. PubMed ID: 6177234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
    Bethge N; Ahuja S; Diel F
    Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medullary carcinoma of the thyroid gland. Clinico-pathologic and immunohistochemical study].
    Elsner B; De Marco L; López S; Curutchet HP
    Medicina (B Aires); 1983; 43(3):263-70. PubMed ID: 6369069
    [No Abstract]   [Full Text] [Related]  

  • 9. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
    Calmettes C; Moukhtar MS; Milhaud G
    Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma.
    Lloyd RV; Sisson JC; Marangos PJ
    Cancer; 1983 Jun; 51(12):2234-9. PubMed ID: 6342746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.
    Saad MF; Fritsche HA; Samaan NA
    J Clin Endocrinol Metab; 1984 May; 58(5):889-94. PubMed ID: 6707192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical detection of calcitonin, ACTH, beta-MSH, beta-endorphin and somatostatin in medullary carcinoma of the thyroid. Immunoperoxidase study (PAP, ABC) of 10 cases].
    Charpin C; Argemi B; Cannoni M; Oliver C; Gillioz P; Vagneur JP; Toga M
    Ann Pathol; 1984; 4(1):27-35. PubMed ID: 6142718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma.
    Busnardo B; Girelli ME; Simioni N; Nacamulli D; Busetto E
    Cancer; 1984 Jan; 53(2):278-85. PubMed ID: 6690009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosubstances in medullary carcinoma of the thyroid.
    Martin-Lacave I; Gonzalez-Campora R; Moreno Fernandez A; Sachez Gallego F; Montero C; Galera-Davidson H
    Histopathology; 1988 Jul; 13(1):55-66. PubMed ID: 3209191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed medullary and follicular carcinoma of the thyroid.
    Pfaltz M; Hedinger CE; Mühlethaler JP
    Virchows Arch A Pathol Anat Histopathol; 1983; 400(1):53-9. PubMed ID: 6407193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of immunohistochemistry in medullary thyroid carcinoma: a systematic study of 30 cases.
    Krisch K; Krisch I; Horvat G; Neuhold N; Ulrich W
    Histopathology; 1985 Oct; 9(10):1077-89. PubMed ID: 2417931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid antibodies.
    Sobrinho-Simões M; Nesland JM; Johannessen JV
    Am J Surg Pathol; 1987 Oct; 11(10):821-4. PubMed ID: 3661825
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyroid-associated antigens in routinely embedded carcinomas. Possibilities and limitations studied in 116 cases.
    Logmans SC; Jöbsis AC
    Cancer; 1984 Jul; 54(2):274-9. PubMed ID: 6202390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family study of serum carcinoembryonic antigen in inherited medullary carcinoma of the thyroid.
    Kodama T; Fujino M; Endo Y; Obara T; Fujimoto Y; Adachi I; Abe K; Oda T; Wada T
    Cancer; 1979 Aug; 44(2):661-4. PubMed ID: 476574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.